Determinants of Patient Experience and Its Association With Symptom Burden and Quality of Life Among Cancer Patients in Nigeria: A Tertiary-Centre Cross-Sectional Study
Determinanten der Patientenerfahrung und ihre Assoziation mit Symptomlast und Lebensqualität bei Krebspatient:innen in Nigeria: eine Querschnittsstudie am Tertiärzentrum
JCO Global Oncology · 01.11.2026 · 12 (Supplement_1) · 31-32
DOI: 10.1200/go-26-31000 ↗Auf einen Blick
Bei 320 Krebspatient:innen in Nigeria waren die Patientenerfahrungswerte hoch, aber nicht mit der Lebensqualität verbunden. Die Symptomlast zeigte dagegen starke Zusammenhänge mit einer geringeren Lebensqualität.
Fragestellung
Wie hängen Patientenerfahrung, Symptomlast und Lebensqualität bei Krebspatient:innen in einem Tertiärzentrum in Nigeria zusammen?
Methode
Querschnittsstudie mit 320 Krebspatient:innen; Erhebung mit validierten patientenberichteten Instrumenten, darunter EORTC PATSAT-C33 und QLQ-C30; Analyse mit Spearman-Korrelation und multivariabler linearer Regression.
Ergebnisse
Die Patientenerfahrung war nicht mit der QoL assoziiert (ρ = –0,012; P = .830; adjustiertes β = –0,090; 95 %-KI –0,340 bis 0,161; P = .481). Schmerz, Depression, Schlafstörung und finanzielle Schwierigkeiten waren unabhängig mit geringerer QoL verbunden.
Schlussfolgerung der Autor:innen
In diesem LMIC-Setting wird die QoL vor allem durch die Symptomlast und nicht durch die wahrgenommene Versorgungserfahrung bestimmt. Trotz hoher Patientenerfahrungswerte bestehen erhebliche unbehandelte Bedürfnisse.
Kernaussagen
- Patientenerfahrung hoch, aber nicht mit QoL verknüpft
- Symptomlast mit geringerer QoL assoziiert
- Unmet needs besonders in psychologischen und finanziellen Bereichen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Querschnittstudie in der Zeitschrift JCO Global Oncology, erschienen am 01.11.2026. Verfasst von Adewumi Alabi und 9 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE Patient experience is increasingly recognised as a quality indicator in oncology, but its relationship with clinically meaningful outcomes such as quality of life (QoL) remains unclear, particularly in resource-limited settings with advanced disease and high unmet supportive care needs. We evaluated patient experience and its association with symptom burden and QoL among cancer patients in a tertiary centre in Nigeria. METHODS We conducted a cross-sectional study of 320 cancer patients. Patient experience, symptom burden, and QoL were assessed using validated patient-reported measures, including the European Organisation for Research and Treatment of Cancer PATSAT-C33 and QLQ-C30 instruments. Associations were examined using Spearman correlation and multivariable linear regression, adjusting for socio-clinical factors. RESULTS The mean age was 46.6 ± 14.7 years; 60.6% were female and 79.4% presented with stage III-IV disease. Patient experience scores were uniformly high (range 4.57-4.85) with minimal variability. In contrast, substantial symptom burden was observed: severe pain in 63 (19.8%), sleep disturbance in 233 (72.8%), depressive symptoms in 218 (68.1%), including 122 (38.1%) moderate-to-severe, and financial difficulties in 232 (72.5%), with 128 (40.0%) moderate-to-severe burden. Patient experience was not associated with QoL (ρ = –0.012; P = .830; adjusted β = –0.090; 95% CI –0.340 to 0.161; P = .481). By contrast, symptom burden showed strong independent associations with reduced QoL, including pain (β ≈ –0.80; P = .0001), depression (β ≈ –0.90; P = .0001), sleep disturbance (β ≈ –0.70; P = .0002), and financial difficulties (β ≈ –0.80; P = .0001). CONCLUSION In this LMIC setting, QoL is driven predominantly by symptom burden rather than perceived care experience. Despite high patient experience scores, substantial unmet needs persist, particularly in psychological and financial domains. These findings highlight a disconnect between reported experience and actual well-being, and support prioritising integrated psycho-oncology services, symptom-directed supportive care, and financial toxicity interventions to improve patient-centred outcomes.
Zitieren
APA
Alabi, A., Eze, C. G., Sowunmi, A., Adegboyega, B., Fatiregun, O. A., Aje, E., Ololade, K., Andero, T., Oshikanlu, B., & Habeebu, M. (2026). Determinants of Patient Experience and Its Association With Symptom Burden and Quality of Life Among Cancer Patients in Nigeria: A Tertiary-Centre Cross-Sectional Study. JCO Global Oncology, 12(Supplement_1), 31-32. https://doi.org/10.1200/go-26-31000
Vancouver
Alabi A, Eze CG, Sowunmi A, Adegboyega B, Fatiregun OA, Aje E, et al. Determinants of Patient Experience and Its Association With Symptom Burden and Quality of Life Among Cancer Patients in Nigeria: A Tertiary-Centre Cross-Sectional Study. JCO Global Oncology. 2026;12(Supplement_1):31-32. doi:10.1200/go-26-31000
BibTeX
@article{Alabi2026,
author = {Alabi, Adewumi and Eze, Chukwuebuka Godspower and Sowunmi, Anthonia and Adegboyega, Bolanle and Fatiregun, Olamijulo Adedeji and Aje, Eben and Ololade, Kehinde and Andero, Temitope and Oshikanlu, Bukola and Habeebu, Muhammad},
title = {Determinants of Patient Experience and Its Association With Symptom Burden and Quality of Life Among Cancer Patients in Nigeria: A Tertiary-Centre Cross-Sectional Study},
journal = {JCO Global Oncology},
year = {2026},
volume = {12},
number = {Supplement_1},
pages = {31--32},
doi = {10.1200/go-26-31000}
}
EUVIMED